Ask them about their support system for managing side effects, counselling for diet, protein intake, and muscle preservation
The preclinical studies on GLP-1 receptor agonists have been comprehensively summarized in Table 2
Here is a quick reference: Split-dose reference: 8mg at 5mg/mL Split-dose reference: 12mg at 5mg/mL Wait
The weight loss achieved varies by specific medication and dose: semaglutide 2.4 mg (Wegovy) produces approximately 15% weight loss, tirzepatide (Zepbound) up to 15-22%, and liraglutide 3 mg (Saxenda) about 5-8%
As for nonfatal stroke, GLP-1 RA are the only drug class that significantly reduces nonfatal stroke, as compared with placebo, without any difference among the three classes of drugs
How to know if your microdose is working Three signals that your current dose is effective: Reduced appetite without nausea : Youre eating less because youre genuinely satisfied, not because you feel sick